Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo.

Two analogues of the N-terminal part of bacterial lipoprotein, S-[2,3-bis(palmitoyloxy)-(2RS)propyl]-N-palmitoyl-(R)-cysteine methyl ester ("tripalmitoyl cysteine") and S [-2,3-bis(palmitoyloxy)-(2RS)-propyl]-N-palmitoyl-(R)-cysteinyl-(S)-seryl-(S)-seryl-(S)-asparaginyl-(S)-alanine ("tripalmitoyl pentapeptide") were synthesized and tested for mitogenic activity. The compounds were potent mitogens towards mouse spleen cell cultures, as measured by 3H-thymidine incorporation and by hemolytic plaque assays. This activity was not dependent on the presence of serum. Tripalmitoyl pentapeptide had little, if any, effect on thymocytes. When injected intravenously into Balb/c mice, the synthetic compounds induced splenomegaly and polyclonal B-cell activation, the latter was evident from an increase in the number of plaque-forming cells against trinitrophenylated sheep red blood cells. Thus, a synthetic fragment of a bacterial surface component was shown to exhibit marked biological activity in vitro as well as in vivo.